mTOR inhibitor augments the antitumor effect of p53-expressing oncolytic adenovirus in human neuroblastoma cells

被引：0
|
作者：
Tanimoto, Terutaka [1 ]
Tazawa, Hiroshi [1 ]
Noso, Hiroshi [1 ]
Tani, Morimichi [1 ]
Oyama, Takanori [1 ]
Urata, Yasuo [2 ]
Kagawa, Shunsuke [1 ]
Noda, Takuo [1 ]
Fujiwara, Toshiyoshi [1 ]
机构：
[1] Okayama Univ, Okayama, Japan
[2] Oncolys Biopharma Inc, Okayama, Japan
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-3177
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3177
引用
收藏
页数：2
相关论文
共 50 条
  • [31] An oncolytic adenovirus expressing interleukin-24 enhances antitumor activities in combination with paclitaxel in breast cancer cells
    Fang, Lin
    Cheng, Qian
    Bai, Jin
    Qi, Ying-Dong
    Liu, Jun-Jie
    Li, Lian-Tao
    Zheng, Jun-Nian
    MOLECULAR MEDICINE REPORTS, 2013, 8 (05) : 1416 - 1424
  • [32] Combined therapy with CTL cells and oncolytic adenovirus expressing IL-15-induced enhanced antitumor activity
    Yan, Yang
    Li, Songyan
    Jia, Tingting
    Du, Xiaohui
    Xu, Yingxin
    Zhao, Yunshan
    Li, Li
    Liang, Kai
    Liang, Wentao
    Sun, Huiwei
    Li, Rong
    TUMOR BIOLOGY, 2015, 36 (06) : 4535 - 4543
  • [33] Combination of autophagy inducer rapamycin and oncolytic adenovirus improves antitumor effect in cancer cells
    Pei-Hsin Cheng
    Serena Lian
    Robin Zhao
    Xiao-Mei Rao
    Kelly M McMasters
    Heshan Sam Zhou
    Virology Journal, 10
  • [34] Combination of CDK4/6 inhibitor promotes the antitumor effect of oncolytic adenovirus against canine breast cancer cells
    Hashimoto, Naoyuki
    Tazawa, Hiroshi
    Kikuchi, Satoru
    Kuroda, Shinji
    Urata, Yasuo
    Kagawa, Shunsuke
    Fujiwara, Toshiyoshi
    CANCER RESEARCH, 2024, 84 (06)
  • [35] Combination of autophagy inducer rapamycin and oncolytic adenovirus improves antitumor effect in cancer cells
    Cheng, Pei-Hsin
    Lian, Serena
    Zhao, Robin
    Rao, Xiao-Mei
    McMasters, Kelly M.
    Zhou, Heshan Sam
    VIROLOGY JOURNAL, 2013, 10
  • [36] Scoring system to predict antitumor effects of p53-armed telomerase-specific oncolytic adenovirus
    Sugimoto, Ryoma
    Kuroda, Shinji
    Yoshida, Yusuke
    Sakamoto, Masaki
    Hamada, Yuki
    Yagi, Chiaki
    Hashimoto, Masashi
    Kakiuchi, Yoshihiko
    Kikuchi, Satoru
    Kagawa, Shunsuke
    Tazawa, Hiroshi
    Urata, Yasuo
    Fujiwara, Toshiyoshi
    CANCER SCIENCE, 2023, 114 : 2210 - 2210
  • [37] Enhanced antitumor effect of interleukin-12 and B37.1 expressing oncolytic adenovirus in immunocompetent mouse
    Lee, YS
    Cho, KJ
    Cho, SG
    Yun, CO
    Kim, JH
    MOLECULAR THERAPY, 2004, 9 : S219 - S220
  • [38] PI3K inhibitor LY294002 inhibits activation of the Akt/mTOR pathway induced by an oncolytic adenovirus expressing TRAIL and sensitizes multiple myeloma cells to the oncolytic virus
    Tong, Yin
    Zhu, Weiwei
    Huang, Xianbo
    You, Liangshun
    Han, Xiujun
    Yang, Chunmei
    Qian, Wenbin
    ONCOLOGY REPORTS, 2014, 31 (04) : 1581 - 1588
  • [39] 11R-P53 and GM-CSF Expressing Oncolytic Adenovirus Target Cancer Stem Cells with Enhanced Synergistic Activity
    Lv, Sai-qun
    Ye, Zhen-long
    Liu, Pin-yi
    Huang, Yao
    Li, Lin-fang
    Liu, Hui
    Zhu, Hai-li
    Jin, Hua-jun
    Qian, Qi-jun
    JOURNAL OF CANCER, 2017, 8 (02): : 199 - 206
  • [40] Sodium Arsenite ± Hyperthermia Sensitizes p53-Expressing Human Ovarian Cancer Cells to Cisplatin by Modulating Platinum-DNA Damage Responses
    Muenyi, Clarisse S.
    Pinhas, Allan R.
    Fan, Teresa W.
    Brock, Guy N.
    Helm, C. William
    States, J. Christopher
    TOXICOLOGICAL SCIENCES, 2012, 127 (01) : 139 - 149
12345